OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 64 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,116,000 | -37.4% | 634,650 | -36.8% | 0.00% | 0.0% |
Q3 2016 | $4,979,000 | +2.9% | 1,003,911 | +5.6% | 0.00% | 0.0% |
Q2 2016 | $4,838,000 | -10.5% | 950,541 | +0.4% | 0.00% | 0.0% |
Q1 2016 | $5,406,000 | -42.8% | 946,723 | +4.1% | 0.00% | -50.0% |
Q4 2015 | $9,444,000 | -48.5% | 909,847 | -8.4% | 0.00% | -60.0% |
Q3 2015 | $18,354,000 | -0.9% | 993,702 | +4.4% | 0.01% | +25.0% |
Q2 2015 | $18,530,000 | +9.1% | 952,229 | -1.4% | 0.00% | 0.0% |
Q1 2015 | $16,982,000 | +13.4% | 965,960 | +3.1% | 0.00% | 0.0% |
Q4 2014 | $14,980,000 | +36.4% | 936,830 | +7.4% | 0.00% | +33.3% |
Q3 2014 | $10,986,000 | -19.5% | 872,630 | -0.1% | 0.00% | -25.0% |
Q2 2014 | $13,644,000 | +17.4% | 873,491 | -1.3% | 0.00% | +33.3% |
Q1 2014 | $11,620,000 | -14.1% | 884,979 | +5.2% | 0.00% | -25.0% |
Q4 2013 | $13,524,000 | -1.7% | 841,019 | +1.8% | 0.00% | -20.0% |
Q3 2013 | $13,754,000 | +89.9% | 826,536 | +14.9% | 0.01% | +66.7% |
Q2 2013 | $7,243,000 | – | 719,262 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venator Capital Management Ltd. | 218,300 | $4,248,000 | 3.89% |
Consonance Capital Management LP | 1,176,195 | $22,889,000 | 2.30% |
RATIONAL ADVISORS LLC | 64,000 | $1,245,000 | 0.40% |
PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $678,000 | 0.36% |
TURNER INVESTMENTS LLC | 91,500 | $1,780,000 | 0.33% |
FALCON POINT CAPITAL, LLC | 26,596 | $518,000 | 0.18% |
Freedom Investment Management, Inc. | 76,469 | $1,488,000 | 0.15% |
Baker Brothers Advisors | 499,193 | $9,714,000 | 0.08% |
Spark Investment Management LLC | 27,600 | $536,000 | 0.08% |
OXFORD ASSET MANAGEMENT LLP | 128,247 | $2,496,000 | 0.07% |